ChemoMetec

About ChemoMetec

ChemoMetec A/S, founded in 1997 and headquartered in Allerød, Denmark, is a global company specializing in the development, production, and sale of high-precision analytical instruments for cell counting and cell analysis. Its technologies are based on proprietary image cytometry and advanced image analysis, allowing automated and accurate measurement of cell concentration, viability, and other key biological parameters across a wide range of cell types, including mammalian, yeast, sperm, and somatic cells.

The company serves customers in biotechnology, pharmaceuticals, academic research, and industrial sectors. Its instruments are widely used in fields such as cell and gene therapy, stem cell and cancer research, bioprocessing, and quality control in food and agriculture. ChemoMetec’s devices are also used for applications such as semen quality assessment and milk analysis, reflecting the versatility of its analytical platforms.

Its flagship product line, the NucleoCounter® series (including models such as NC-202™, NC-200™, and NC-3000™), provides fully automated, high-accuracy cell counting and viability analysis. These instruments are complemented by image cytometers, consumables such as pre-filled cassettes and reagents, and software designed for regulated laboratory environments under GMP standards.

ChemoMetec emphasizes reproducibility, simplicity, and automation, reducing user error and improving throughput in laboratory workflows. All its instruments are designed, manufactured, and tested in Denmark, ensuring consistent quality and performance. The company is publicly listed on the Copenhagen Stock Exchange under the ticker CHEMM and has a growing global presence supported by a strong reputation in life sciences instrumentation.